Bharat Biotech COVAXIN

FILE PHOTO: A medic fills a syringe with COVAXIN, an Indian government-backed experimental COVID-19 vaccine, before administering it to a health worker during its trials, in Ahmedabad

‘Impossible to Fully Vaccinate All Adults in 2021, Govt Mistakes to Blame’

Karan Thapar 06/08/2021

Health policy expert R. Ramakumar estimated that, at the...

covid

Many States Say COVID Vaccine Expansion Unlikely Before Third Week of May

Amrit B.L.S. 28/04/2021

Vaccine manufacturers Serum Institute and Bharat Biotech have not...

COVID-19 vaccination in Mumbai

Bharat Biotech To See if Third Covaxin Dose Can Provide Protection for Longer

The Wire Staff 02/04/2021

The subject expert committee of the country's top drug...

COVID-19 vaccination in New Delhi

Brazil’s Health Regulator Anvisa Says Covaxin Doesn’t Meet Manufacturing Standards

The Wire Staff 30/03/2021

The Brazil government had signed a contract with Precis...

COVID-19 vaccination in New Delhi

Bharat Biotech’s Study Says Covaxin Is Likely Effective Against UK Variant

Krishna N. Das 27/01/2021

"It is unlikely that the mutation 501Y would be...

Coronavirus disease (COVID-19) outbreak in New Delhi

Govt Doctors Association in Karnataka Demands Choice Between Vaccines

In a letter to the state health minister, the...

COVID -19 vaccination drive starts at Max Hospital

Vaccines Safe, Only 0.18% Adverse Events: Govt

NITI Aayog member V.K. Paul said concerns about adverse...